Articles

Super Micro continued to exhibit margin pressure in the latest quarter, reflecting a competitive server market.

Upstart’s December-quarter revenue is expected to slow more than Wall Street had been modeling.

The White House is close to announcing a deal with drugmakers Eli Lilly and Novo Nordisk that would cut the price of obesity drugs to $149 per month in some cases and extend coverage to certain Medicare and Medicaid beneficiaries, according to media reports Tuesday.

This overlooked area of tech is making money for investors.

The software company is boosting its outlook, and its CEO is cheering gains for retail investors.

Last week Amazon CEO Andy Jassy hinted at more big deals. The $38 billion OpenAI partnership proves he wasn’t kidding.

Bitcoin has broken below an important technical level, which could signal further downside for the crypto, one analyst says.

Third Point looked overseas to find a cheaper way to play the memory-chip boom.

Sarepta’s stock sank after studies of Duchenne muscular dystrophy treatments failed their primary endpoints.

Telehealth company Hims & Hers says it is in “active discussions” with Novo Nordisk about selling Wegovy.

The U.S. coffee-shop chain is forming a joint venture with Boyu Capital, with Boyu holding 60% interest in the company’s retail operations in China. Starbucks will retain the other 40% and continue to own and license the Starbucks brand and intellectual property in the new entity.

The largest companies have seen their weighting in the S&P 500 rise more quickly than their share of total earnings